Microlife bpa 3.2.5 us market
Based on components, the market is divided into two segments devices and software. Based on the conditions, the market is categorized into congestive heart failure (CHF), diabetes, chronic obstructive pulmonary disease (COPD), blood pressure, mental health, and others. The report covers the analysis of remote patient monitoring devices market based on conditions, components, and geography. REMOTE PATIENT MONITORING MARKET SEGMENTATION PERCENTAGE OF DEATHS CAUSED DUE TO NON-COMMUNICABLE DISEASES (NCD) IN 2012 Remote health monitoring technologies focus on serious, chronic conditions, such as congestive heart failure (CHF), pulmonary fibrosis, and diabetes, as they tend to result in repeated hospitalization. These are the major four non-communicable diseases (NCDs) which were responsible for 82% of the deaths worldwide. On the short- and long-term basis, by proper implementation, RPM technologies can expand access to quality healthcare, and save time and money.Īccording to WHO, the leading causes of deaths in 2012 were: cardiovascular diseases, respiratory diseases, including asthma and chronic obstructive pulmonary disease, and diabetes. Moreover, these technologies decrease a number of unnecessary trips to the doctor’s office and reduce travel-related expenses that are necessary to receive quality medical care. Thus, it reduces the readmissions and prevents avoidable hospitalizations. Here, RPM technologies comes into role play and identifies small changes in the patient’s physiological data and promote self-monitoring. The increase in prevalence of chronic conditions places an enormous financial burden on the caregivers. Chronic care management accounts for 75% of the healthcare costs. Get more information on this report : Request Sample PagesĬhronic heart diseases, diabetes, and chronic respiratory diseases are the leading cause of mortality and morbidity in the world. In addition, the increase in incidences of chronic diseases, such as diabetes and COPD, are responsible for the high growth rate. This is attributed to the large undiagnosed patient population, improving access to healthcare systems, and a high risk of developing chronic disease due to rapid urbanization. This reduces the number of emergency department visits, and duration of hospitalization. RPM is used to remotely monitor and analyze physiological parameters such as blood oxygen levels, vital signs, blood pressure, heart rate, and blood sugar, which improves the quality of care, quality of life, and allows early prediction of aggravations and exacerbations. Remote patient monitoring (RPM) is a technology used to collect medical and health-related data from individuals at one location and electronically transmit it to a healthcare provider at another location. The Global Remote Patient Monitoring Market size was $703 million in 2015 and is expected to grow at a CAGR of 17.0% to reach $2,130 million by 2022. Remote Patient Monitoring Market Overview: